Article

Multi-tissue proteomic signatures of Alzheimer’s disease: a systematic investigation in brain, CSF, blood and an exploratory study in tears

2025-01-15

Abstract excerpt

Proteomic studies have the potential to identify etiological biomarker and interventional targets for Alzheimer’s disease (AD). However, limited studies have systematically investigated and compared the proteomic profiling related to AD across multiple tissues. First, we systematically reviewed 112 proteomic studies of AD (comprising 107 case-control studies of 16,997 individuals and 5 prospective cohort studies o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d79190c5-af13-547b-8d75-5b775320ca8b
DOI: 10.1101/2025.01.14.25320538

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multi-tissue proteomic signatures of Alzheimer’s disease: a systematic investigation in brain, CSF, blood and an exploratory study in tearsDOI 10.1101/2025.01.14.25320538Read

Multi-tissue proteomics identifies molecular signatures for sporadic and genetically defined Alzheimer disease casesSemantic proximity Read

Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer’s diseaseSemantic proximity Read

Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discoverySemantic proximity Read

Proteome-wide association study identifies novel Alzheimer's disease- associated proteinsSemantic proximity Read

Identification of Novel Biomarkers for Alzheimer’s Disease and Related Dementias Using Unbiased Plasma ProteomicsSemantic proximity Read

Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuumSemantic proximity Read

High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer’s disease phenotypes in a large mixed dementia cohortSemantic proximity Read

Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profilesSemantic proximity Read

Proteomic Signatures of Neuropathological Alterations in Alzheimer’s Disease: Insights from the Bio-Hermes StudySemantic proximity Read

Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s Disease related proteinsSemantic proximity Read

A genetic and proteomic comparison of key AD biomarkers across tissuesSemantic proximity Read

High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer's disease phenotypes in a large mixed-dementia cohort.Semantic proximity Read